Two new dry powder inhalers will soon hit the market

    Two new DRY POWDER inhalers will soon hit the market...Glaxo's Flovent Rotadisk and Serevent Diskus.

    These have been developed as an alternative to aerosol MDIs...because of the upcoming ban on chlorofluorocarbon propellants.

    Dry powder inhalers are also easier for some patients to use. They're breath-activated...patients DON'T have to coordinate their breathing with the actuation of the inhaler.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote